QUIDELORTHO CORP Noncash or Part Noncash Acquisition, Fixed Assets Acquired
QUIDELORTHO CORP (QDEL) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $8.10 million for the 6-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2026-08-07
- QUIDELORTHO CORP noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2026-06-28 was $1.90M, a 70.77% decline year-over-year.
- QUIDELORTHO CORP noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2026-03-29 was $6.20M, a 38.61% decline year-over-year.
- QUIDELORTHO CORP noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-12-28 was $8.90M, a 9.18% decline year-over-year.
- QUIDELORTHO CORP noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-09-28 was -$12.20M, a 287.69% decline year-over-year.
- QUIDELORTHO CORP noncash or part noncash acquisition, fixed assets acquired for fiscal 2025 was $13.30M, a 48.65% decline from fiscal 2024.
- QUIDELORTHO CORP noncash or part noncash acquisition, fixed assets acquired for fiscal 2024 was $25.90M, a 36.21% decline from fiscal 2023.
- QUIDELORTHO CORP noncash or part noncash acquisition, fixed assets acquired for fiscal 2023 was $40.60M, a 0.50% increase from fiscal 2023.
- QUIDELORTHO CORP noncash or part noncash acquisition, fixed assets acquired for fiscal 2023 was $40.40M, a 284.76% increase from fiscal 2022.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month |
|---|---|---|---|---|
| 2026-06-28 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $8.10M 10-Q · filed 2026-08-07 | $17.00M derived: sum of 3 quarters · filed 2026-08-07 | $4.80M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-29 | $6.20M 10-Q · filed 2026-05-06 | $15.10M derived: sum of 2 quarters · filed 2026-05-06 | $2.90M derived: sum of 3 quarters · filed 2026-05-06 | $9.40M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-28 | $8.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$3.30M derived: sum of 2 quarters · filed 2026-02-19 | $3.20M derived: sum of 3 quarters · filed 2026-08-07 | $13.30M 10-K · filed 2026-02-19 |
| 2025-09-28 | -$12.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$5.70M derived: sum of 2 quarters · filed 2026-08-07 | $4.40M 10-Q · filed 2025-11-06 | $14.20M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-29 | $6.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $16.60M 10-Q · filed 2026-08-07 | $26.40M derived: sum of 3 quarters · filed 2026-08-07 | $32.90M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-30 | $10.10M 10-Q · filed 2026-05-06 | $19.90M derived: sum of 2 quarters · filed 2026-05-06 | $26.40M derived: sum of 3 quarters · filed 2026-05-06 | $28.40M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-29 | $9.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $16.30M derived: sum of 2 quarters · filed 2026-02-19 | $18.30M derived: sum of 3 quarters · filed 2026-02-19 | $25.90M 10-K · filed 2026-02-19 |
| 2024-09-29 | $6.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $8.50M derived: sum of 2 quarters · filed 2025-11-06 | $16.10M 10-Q · filed 2025-11-06 | $45.30M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $9.60M 10-Q · filed 2025-08-06 | $38.80M derived: sum of 3 quarters · filed 2026-02-19 | $31.60M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $7.60M 10-Q · filed 2025-05-08 | $36.80M derived: sum of 2 quarters · filed 2026-02-19 | $29.60M derived: sum of 3 quarters · filed 2026-02-19 | $28.40M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $29.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $22.00M derived: sum of 2 quarters · filed 2026-02-19 | $20.80M derived: sum of 3 quarters · filed 2026-02-19 | $40.60M 10-K · filed 2026-02-19 |
| 2023-10-01 | -$7.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$8.40M derived: sum of 2 quarters · filed 2024-11-08 | $11.40M 10-Q · filed 2024-11-08 | $34.40M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-07-02 | -$1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $18.60M 10-Q · filed 2024-08-01 | $41.60M derived: sum of 3 quarters · filed 2025-02-27 | $56.20M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-04-02 | $19.80M 10-Q · filed 2024-05-09 | $42.80M derived: sum of 2 quarters · filed 2025-02-27 | $57.40M derived: sum of 3 quarters · filed 2025-02-27 | $46.50M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-01-01 | $23.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $37.60M derived: sum of 2 quarters · filed 2025-02-27 | $26.70M derived: sum of 3 quarters · filed 2025-02-27 | $40.40M 10-K · filed 2025-02-27 |
| 2022-10-02 | $14.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $3.70M derived: sum of 2 quarters · filed 2023-11-02 | $17.40M 10-Q · filed 2023-11-02 | $20.20M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-07-03 | -$10.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $2.80M 10-Q · filed 2023-08-09 | $5.60M derived: sum of 3 quarters · filed 2024-08-01 | -$17.90M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-04-03 | $13.70M 10-Q · filed 2023-05-04 | $16.50M derived: sum of 2 quarters · filed 2024-08-01 | -$7.00M derived: sum of 3 quarters · filed 2024-08-01 | |
| 2022-01-02 | $2.80M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-01 | -$20.70M derived: sum of 2 quarters · filed 2024-08-01 | $10.50M 10-K/A · filed 2024-08-01 | |
| 2021-10-03 | -$23.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $7.70M 10-Q · filed 2022-11-04 | ||
| 2021-07-04 | $31.20M 10-Q · filed 2022-08-05 | |||
| 2021-01-03 | $7.20M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |